THE AGENDA
The World Affordable Medicines Congress Europe is Europe’s premier business event providing a comprehensive review of affordable medicine business strategy. The congress brings together two world class events – World Generic Medicines Congress and Biosimilar Drug Development World – that have been central to the industry’s business and networking needs for over 10 years.
The event unites senior executives from the generic and biosimilar industry to provide fresh insights into future market trends, innovative commercial strategies and opportunities for growth for affordable medicines.
Through a mixture of plenary keynote sessions, roundtables, focused work streams, the event will address a comprehensive range of key topics, including:
- Making medicines affordable
- CEO Panel
- Building scale and market share
- Mature and emerging market review
- Payers perspective and pricing trends
- Biosimilar development challenges
- Pharmacovogilance and post-launch safety monitoring
- Clinical development strategies
- Developments in global intellectual property
- Regulatory strategy for generics and biosimilars
- How is the health policy landscape supporting affordable medicines?
- How to develop an integrated approach to biosimilar development & commercialization
Presentations will be delivered by:
- CEOs and MDs from big, small and medium sized generic and biosimilar companies
- Regulators, payers and policy makers from the major international markets
- Senior scientists, IP and pharmacovigilance professionals
- Major service providers in this sector
For speaking opportunities, contact
Lucy Nicholas
at
+44 207 092 1094
or
lucy.nicholas@terrapinn.com
Organiser
